Med4Cast S.A. announced that it has received CHF 12,500 at par value on March 29, 2022. The transition included participation from new investor, Katalysen Ventures AB (publ) who owns 20% stake of the company as a part of the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.3 SEK | +0.66% |
|
+8.51% | +15.91% |
05-21 | Katalysen Ventures AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-15 | Katalysen Ventures Portfolio Company Files for Bankruptcy | MT |
1st Jan change | Capi. | |
---|---|---|
+15.91% | 10.85M | |
+25.31% | 3.29B | |
+12.50% | 1.76B | |
+12.81% | 1.57B | |
-11.54% | 1.22B | |
+29.14% | 852M | |
+8.75% | 651M | |
+53.05% | 625M | |
-4.17% | 502M | |
+25.16% | 463M |
- Stock Market
- Equities
- KAV Stock
- News Katalysen Ventures AB
- Med4Cast S.A. announced that it has received funding from Katalysen Ventures AB